208 related articles for article (PubMed ID: 30213581)
1. Association Between Plasma Level of Collagen Type III Alpha 1 Chain and Development of Strictures in Pediatric Patients With Crohn's Disease.
Ballengee CR; Stidham RW; Liu C; Kim MO; Prince J; Mondal K; Baldassano R; Dubinsky M; Markowitz J; Leleiko N; Hyams J; Denson L; Kugathasan S
Clin Gastroenterol Hepatol; 2019 Aug; 17(9):1799-1806. PubMed ID: 30213581
[TBL] [Abstract][Full Text] [Related]
2. Biomarkers for the Prediction and Diagnosis of Fibrostenosing Crohn's Disease: A Systematic Review.
Steiner CA; Berinstein JA; Louissaint J; Higgins PDR; Spence JR; Shannon C; Lu C; Stidham RW; Fletcher JG; Bruining DH; Feagan BG; Jairath V; Baker ME; Bettenworth D; Rieder F;
Clin Gastroenterol Hepatol; 2022 Apr; 20(4):817-846.e10. PubMed ID: 34089850
[TBL] [Abstract][Full Text] [Related]
3. Serum immune responses predict rapid disease progression among children with Crohn's disease: immune responses predict disease progression.
Dubinsky MC; Lin YC; Dutridge D; Picornell Y; Landers CJ; Farrior S; Wrobel I; Quiros A; Vasiliauskas EA; Grill B; Israel D; Bahar R; Christie D; Wahbeh G; Silber G; Dallazadeh S; Shah P; Thomas D; Kelts D; Hershberg RM; Elson CO; Targan SR; Taylor KD; Rotter JI; Yang H;
Am J Gastroenterol; 2006 Feb; 101(2):360-7. PubMed ID: 16454844
[TBL] [Abstract][Full Text] [Related]
4. Serum Protein Biomarkers of Fibrosis Aid in Risk Stratification of Future Stricturing Complications in Pediatric Crohn's Disease.
Wu J; Lubman DM; Kugathasan S; Denson LA; Hyams JS; Dubinsky MC; Griffiths AM; Baldassano RN; Noe JD; Rabizadeh S; Gulati AS; Rosh JR; Crandall WV; Higgins PDR; Stidham RW
Am J Gastroenterol; 2019 May; 114(5):777-785. PubMed ID: 31058681
[TBL] [Abstract][Full Text] [Related]
5. Granulocyte-macrophage colony-stimulating factor autoantibodies: a marker of aggressive Crohn's disease.
Gathungu G; Kim MO; Ferguson JP; Sharma Y; Zhang W; Ng SM; Bonkowski E; Ning K; Simms LA; Croft AR; Stempak JM; Walker N; Huang N; Xiao Y; Silverberg MS; Trapnell B; Cho JH; Radford-Smith GL; Denson LA
Inflamm Bowel Dis; 2013 Jul; 19(8):1671-80. PubMed ID: 23749272
[TBL] [Abstract][Full Text] [Related]
6. Blood-Derived DNA Methylation Signatures of Crohn's Disease and Severity of Intestinal Inflammation.
Somineni HK; Venkateswaran S; Kilaru V; Marigorta UM; Mo A; Okou DT; Kellermayer R; Mondal K; Cobb D; Walters TD; Griffiths A; Noe JD; Crandall WV; Rosh JR; Mack DR; Heyman MB; Baker SS; Stephens MC; Baldassano RN; Markowitz JF; Dubinsky MC; Cho J; Hyams JS; Denson LA; Gibson G; Cutler DJ; Conneely KN; Smith AK; Kugathasan S
Gastroenterology; 2019 Jun; 156(8):2254-2265.e3. PubMed ID: 30779925
[TBL] [Abstract][Full Text] [Related]
7. Serologic testing with ANCA, ASCA, and anti-OmpC in children and young adults with Crohn's disease and ulcerative colitis: diagnostic value and correlation with disease phenotype.
Zholudev A; Zurakowski D; Young W; Leichtner A; Bousvaros A
Am J Gastroenterol; 2004 Nov; 99(11):2235-41. PubMed ID: 15555007
[TBL] [Abstract][Full Text] [Related]
8. Association of antibody responses to microbial antigens and complications of small bowel Crohn's disease.
Mow WS; Vasiliauskas EA; Lin YC; Fleshner PR; Papadakis KA; Taylor KD; Landers CJ; Abreu-Martin MT; Rotter JI; Yang H; Targan SR
Gastroenterology; 2004 Feb; 126(2):414-24. PubMed ID: 14762777
[TBL] [Abstract][Full Text] [Related]
9. Increased prevalence of luminal narrowing and stricturing identified by enterography in pediatric Crohn's disease patients with elevated granulocyte-macrophage colony stimulating factor autoantibodies.
Dykes DM; Towbin AJ; Bonkowski E; Chalk C; Bezold R; Lake K; Kim MO; Heubi JE; Trapnell BC; Podberesky DJ; Denson LA
Inflamm Bowel Dis; 2013 Sep; 19(10):2146-54. PubMed ID: 23893081
[TBL] [Abstract][Full Text] [Related]
10. Age of diagnosis influences serologic responses in children with Crohn's disease: a possible clue to etiology?
Markowitz J; Kugathasan S; Dubinsky M; Mei L; Crandall W; LeLeiko N; Oliva-Hemker M; Rosh J; Evans J; Mack D; Otley A; Pfefferkorn M; Bahar R; Vasiliauskas E; Wahbeh G; Silber G; Quiros JA; Wrobel I; Nebel J; Landers C; Picornell Y; Targan S; Lerer T; Hyams J
Inflamm Bowel Dis; 2009 May; 15(5):714-9. PubMed ID: 19107777
[TBL] [Abstract][Full Text] [Related]
11. Measurement of Fibrosis in Crohn's Disease Strictures with Imaging and Blood Biomarkers to Inform Clinical Decisions.
Higgins PD
Dig Dis; 2017; 35(1-2):32-37. PubMed ID: 28147365
[TBL] [Abstract][Full Text] [Related]
12. Real-Time Shear Wave Ultrasound Elastography Differentiates Fibrotic from Inflammatory Strictures in Patients with Crohn's Disease.
Chen YJ; Mao R; Li XH; Cao QH; Chen ZH; Liu BX; Chen SL; Chen BL; He Y; Zeng ZR; Ben-Horin S; Rimola J; Rieder F; Xie XY; Chen MH
Inflamm Bowel Dis; 2018 Sep; 24(10):2183-2190. PubMed ID: 29718309
[TBL] [Abstract][Full Text] [Related]
13. Anti-Outer membrane protein C and anti-glycoprotein 2 antibodies in inflammatory bowel disease and their association with complicated forms of Crohn's disease.
Kohoutova D; Drahosova M; Moravkova P; Rejchrt S; Bures J
BMC Gastroenterol; 2014 Dec; 14():190. PubMed ID: 25551469
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of Fibroblast Activation Protein Restores a Balanced Extracellular Matrix and Reduces Fibrosis in Crohn's Disease Strictures Ex Vivo.
Truffi M; Sorrentino L; Monieri M; Fociani P; Mazzucchelli S; Bonzini M; Zerbi P; Sampietro GM; Di Sabatino A; Corsi F
Inflamm Bowel Dis; 2018 Jan; 24(2):332-345. PubMed ID: 29361086
[TBL] [Abstract][Full Text] [Related]
15. Granulocyte macrophage colony-stimulating factor auto-antibodies and disease relapse in inflammatory bowel disease.
Däbritz J; Bonkowski E; Chalk C; Trapnell BC; Langhorst J; Denson LA; Foell D
Am J Gastroenterol; 2013 Dec; 108(12):1901-10. PubMed ID: 24145675
[TBL] [Abstract][Full Text] [Related]
16. Misbalance in type III collagen formation/degradation as a novel serological biomarker for penetrating (Montreal B3) Crohn's disease.
van Haaften WT; Mortensen JH; Karsdal MA; Bay-Jensen AC; Dijkstra G; Olinga P
Aliment Pharmacol Ther; 2017 Jul; 46(1):26-39. PubMed ID: 28481042
[TBL] [Abstract][Full Text] [Related]
17. Association of Anti-glycan Antibodies and Inflammatory Bowel Disease Course.
Paul S; Boschetti G; Rinaudo-Gaujous M; Moreau A; Del Tedesco E; Bonneau J; Presles E; Mounsef F; Clavel L; Genin C; Flourié B; Phelip JM; Nancey S; Roblin X
J Crohns Colitis; 2015 Jun; 9(6):445-51. PubMed ID: 25895876
[TBL] [Abstract][Full Text] [Related]
18. Fragments of Citrullinated and MMP-degraded Vimentin and MMP-degraded Type III Collagen Are Novel Serological Biomarkers to Differentiate Crohn's Disease from Ulcerative Colitis.
Mortensen JH; Godskesen LE; Jensen MD; Van Haaften WT; Klinge LG; Olinga P; Dijkstra G; Kjeldsen J; Karsdal MA; Bay-Jensen AC; Krag A
J Crohns Colitis; 2015 Oct; 9(10):863-72. PubMed ID: 26188349
[TBL] [Abstract][Full Text] [Related]
19. Serologic, but Not Genetic, Markers Are Associated With Impaired Anthropometrics at Diagnosis of Pediatric Crohn's Disease.
Naramore SK; Bennett WE; Jiang G; Kugathasan S; Denson LA; Hyams JS; Steiner SJ;
J Pediatr Gastroenterol Nutr; 2019 Nov; 69(5):e129-e134. PubMed ID: 31393333
[TBL] [Abstract][Full Text] [Related]
20. Comparable short- and long-term outcomes of colonoscopic balloon dilation of Crohn's Disease and benign non-Crohn's Disease strictures.
Chen M; Shen B
Inflamm Bowel Dis; 2014 Oct; 20(10):1739-46. PubMed ID: 25153504
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
